Skip to main content

GLP-1 treatment and weight-loss injections

Weight-loss injections can help some people with overweight or obesity when there are clinical indications and the professional considers that the benefits outweigh the possible risks. They are prescription medications and do not replace changes in diet, physical activity or medical follow-up.

Check circleMedical assessment of your health, history, medication and possible contraindications
Check circleInformation about the different weight-loss medications and their characteristics
Check circleElectronic prescription only when the doctor considers there is a clinical indication
GLP-1 treatment and weight-loss injections

How to access weight-loss injections online

Three steps to receive a personalised medical assessment.

How to access weight-loss injections online
1
Choose the doctor you'd like to have the video consultation with and book the time that suits you best.
2
Discuss your weight, how the problem has progressed, your medical history, any associated conditions, your usual medication and your goals related to weight management.
3
The doctor will assess the most suitable options for your situation. When there is a medical indication and no contraindications, they may issue an electronic prescription in accordance with current regulations in Spain.

The video consultation does not guarantee the prescription of a specific medication. All decisions are made exclusively by the doctor, who will act according to their clinical judgement and the information available during the assessment. If you experience severe abdominal pain, persistent vomiting, difficulty breathing, signs of an allergic reaction or any other serious symptom during treatment, seek urgent medical attention. An online consultation does not replace emergency care.

Browse GLP-1 weight loss doctors online

Compare experience, languages and appointment slots, then book a video consultation in minutes through Oladoctor.

Doctor
5.0(12)

Yevgen Yakovenko

General medicine12 years of experience

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Book a video appointment
€72
Doctor
5.0(21)

Nuno Tavares Lopes

General medicine18 years of experience

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies

  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management

  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses

  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment

  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance

  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis

  • Pain management: acute and chronic pain, post-surgical care

  • Public health: prevention, health screenings, long-term monitoring

  • Sick leave (Baixa médica) connected to Segurança Social in Portugal

  • IMT medical certificates for driving licence exchange

Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Book a video appointment
€70
View all doctors

Weight-loss injections: what you need to know

There are different injectable medications used for weight management. Find out how they work, what factors the doctor takes into account, and what aspects can vary before making a decision.

How weight-loss medications work

How weight-loss medications work

These medications mimic the action of a hormone that the body naturally releases after meals. This hormone is involved in regulating appetite, the feeling of fullness and blood glucose control. Some medications also slow down stomach emptying, helping to prolong the feeling of fullness.

Results can vary from person to person and depend on factors such as overall health, diet, level of physical activity, adherence to treatment and medical follow-up. No weight-loss medication offers guaranteed results on its own.

Injectable medication options for weight loss

Injectable medication options for weight loss

There are different injectable weight-loss medications, and not all of them contain the same active ingredient, have the same indications, or are suitable for everyone. The choice depends on an individual medical assessment that takes into account body mass index, medical history, associated conditions, usual medication, tolerance and the availability of the medication.

The frequency of administration, the recommended follow-up and the method of use can also vary. For this reason, weight-loss injections should be part of a treatment plan supervised by a doctor and accompanied by sustainable lifestyle changes.

Semaglutide and tirzepatide: main differences

Semaglutide and tirzepatide: main differences

Available options include injectable semaglutide and tirzepatide in Spain. Both active ingredients can be used in certain patients with overweight or obesity when there is a clinical indication, but they differ in their mechanism of action, authorised indications, follow-up schedule and safety profile.

For this reason, there is no single medication that is the best option for everyone. The choice will depend on medical history, associated conditions, response to treatment and the doctor’s judgement. Other alternatives may also be considered during the consultation if the professional believes a different therapeutic approach would be more suitable.

Once-weekly weight-loss injections

Once-weekly weight-loss injections

Many current treatments are given as once-weekly weight-loss injections, using pre-filled devices designed to make administering the medication easier. These weight-loss pens let you follow the schedule set by the doctor, although the frequency and dose can vary depending on the active ingredient and clinical progress.

The injectable weight-loss pen is simply the delivery system for the medication. Not everyone will use the same device or follow the same schedule. The dose or frequency of administration should never be changed, nor should one medication be swapped for another, without first consulting the professional responsible for your follow-up

Who can be assessed for these options

Who can be assessed for these options

Not everyone who wants to lose weight is a candidate for a weight-loss injection. The decision doesn’t depend solely on body weight or body mass index, but on the overall clinical factors the doctor reviews during the consultation.

The assessment includes personal history, associated conditions, previous weight-management treatments, usual medication, eating habits, level of physical activity and any possible contraindications.

In some cases, the doctor may consider it appropriate to start treatment. In others, they may recommend lifestyle changes, further tests or a different therapeutic strategy.

Safety, contraindications and side effects

Safety, contraindications and side effects

Weight-loss injections require a medical assessment before starting and appropriate follow-up during use. The most common side effects are digestive and include nausea, an early feeling of fullness, vomiting, diarrhoea or constipation, especially during the first few weeks. Tolerance can vary and should be assessed by the doctor.

Before recommending an injectable weight-loss medication, the professional will review your medical history, chronic conditions, allergies, current medication and other factors that could affect safety. It’s also important to mention if you are pregnant, planning a pregnancy, or breastfeeding, as these situations may affect the clinical decision.

If you experience severe abdominal pain, persistent vomiting, difficulty breathing, signs of an allergic reaction or any other serious symptom, seek urgent medical attention.

Price of weight-loss injections and coverage

Price of weight-loss injections and coverage

The total cost usually consists of two parts: the medical consultation and the medication, which is dispensed separately at the pharmacy. The price of weight-loss injections can vary depending on the active ingredient, prescribed dose, presentation and availability at the pharmacy. The medical consultation and the medication are billed separately, and the cost of the medication is not included in the price of the consultation.

Regarding public coverage, weight-loss injections through Spain’s public health system (Seguridad Social) are subject to authorised indications and current regulations. In some cases, partial coverage may also be available through private insurance, depending on the terms of each insurer and policy.

Consulting about these options with Oladoctor

Consulting about these options with Oladoctor

Oladoctor makes it easy to access online medical consultations to assess different options when there is a clinical indication. During the video consultation you can discuss your medical history, the treatments you’re using, your goals related to weight management, and any questions you have about the available medications.

With Oladoctor you can:

  • Choose the doctor and book the consultation online at the time that suits you.
  • Have the consultation by video call from anywhere in Spain.
  • Discuss your medical history, your goals and any treatments you’ve used previously.
  • Receive medical recommendations tailored to your situation.
  • Obtain an electronic prescription only when the doctor considers there is an indication.
  • Know the cost of the consultation before booking, with no subscriptions or hidden fees.

Patients love

Logo

Your guide to healthcare in Spain

Practical information about the healthcare system, doctors and medical services in Spain.

Explore

GLP-1 weight loss FAQ: cost, eligibility, safety & prescriptions

Get quick answers on who qualifies, expected results, side effects, pricing, and how e-prescriptions work

Pharmacy prices depend on country, VAT and dose. As a guide, a four-week pen costs €280 – €450 for semaglutide and €310 – €500 for tirzepatide. Consultation fees on Oladoctor are set individually by each doctor and shown upfront before you book—there’s no platform subscription. If you have private insurance, bring your policy details to the visit so the doctor can complete any paperwork insurers may need for partial reimbursement.

Most doctors prescribe when BMI ≥ 30 kg/m², or ≥ 27 kg/m² plus a weight-related condition such as type 2 diabetes, hypertension or sleep apnoea. Pregnancy, active pancreatitis and certain thyroid cancers are common exclusions. Final approval always rests with the physician.

Expect the scale to nudge downward within the first 8–12 weeks as the dose climbs. Average loss is about 5 % at three months and 12–17 % after a year when medication is paired with balanced eating and light activity.

Mild nausea, fuller-than-usual stomach and occasional constipation are most common, especially during the first month. They usually ease once the dose stabilises. Severe abdominal pain, vomiting or vision changes are rare — contact a doctor or emergency services if they occur.

No crash diets required. Doctors recommend protein-rich meals, smaller portions and at least 150 minutes of weekly movement to protect muscle and support steady fat loss. Avoid high-fat, large meals on injection days to curb nausea.

Pharmacy prices in eligible EU markets range from about €280 to €450 per four-week pen, depending on dose and local VAT. The Oladoctor consultation fee is separate and shown before you book.

Your e-prescription remains valid, but local fill windows vary.

  • Spain: the pharmacy must dispense within 10 days of the issue date. If stock is unavailable, ask the pharmacist to place an immediate back-order and stamp the prescription slip. Should the medicine still not arrive before the 10-day window closes, book a follow-up visit in Oladoctor so the doctor can re-issue or adjust the prescription.
  • Other EU markets typically allow 30 days, but confirm your country’s limit at the time of issue. Where back-orders take longer, your doctor can discuss alternative strengths, compounding solutions, or a temporary switch to another GLP-1 until supply normalises.

Yes. Many users taper once they hit their goal weight, often combined with lifestyle coaching. Others move from semaglutide to tirzepatide for an extra loss “boost.” Any pause or switch should be supervised by your prescribing doctor.

GLP-1 agents rarely interact with most drugs, but they can amplify low-sugar risk if you also use insulin or sulfonylureas. Tell your doctor every medicine and supplement you take so they can adjust doses accordingly.

Coverage varies by country and by the reason the drug is prescribed.

  • Spain. The public system (Seguridad Social) reimburses GLP-1 drugs only for type-2 diabetes, not for weight-loss. Most users pay retail unless their private plan explicitly covers anti-obesity medicines.
  • Portugal. No public subsidy is available for weight-loss use. Some private insurers will reimburse part of the cost when BMI or diabetes criteria are met; check your policy first.
  • Italy. Regional SSN formularies are still drafting rules for obesity coverage. For now, GLP-1s are self-pay unless your private insurance offers a specific obesity benefit.
  • Poland. Public reimbursement applies only to Ozempic for diabetes in limited age groups; weight-management use is self-pay. Private coverage is uncommon but possible on higher-tier plans.

The doctor you book through Oladoctor can supply any medical justification or prior-authorisation forms your private insurer requires, but final approval rests with the insurer. If coverage is denied, ask about manufacturer coupons, pharmacy discount programmes, or compounding options to lower out-of-pocket costs.

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media